{
    "2019-01-29": [
        [
            {
                "time": "",
                "original_text": "复星医药(600196.SH)附属治疗类风湿关节炎适应症药物完成临床I/II期试验",
                "features": {
                    "keywords": [
                        "复星医药",
                        "类风湿关节炎",
                        "临床试验",
                        "药物研发"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "复星医药以75万元转让德尚韵兴0.3214%股权",
                "features": {
                    "keywords": [
                        "复星医药",
                        "股权转让",
                        "德尚韵兴"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "复星医药(02196.HK)：复星平耀拟向投资团队转让德尚韵兴0.3214%股权",
                "features": {
                    "keywords": [
                        "复星医药",
                        "股权转让",
                        "德尚韵兴",
                        "投资团队"
                    ],
                    "sentiment_score": -0.15,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "港股公告精选：禹洲地产拟发行5亿美元优先票据",
                "features": {
                    "keywords": [
                        "禹洲地产",
                        "优先票据",
                        "发行"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "房地产"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "创新药产业链主题性机会凸显 10只概念股获机构推荐",
                "features": {
                    "keywords": [
                        "创新药",
                        "产业链",
                        "主题性机会",
                        "机构推荐"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}